Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
最近の投稿
- 1
Senior's Manual for Obtaining a Hyundai Ioniq EV: Tips - 2Timothy Busfield turns himself in to face child sexual abuse charges in New Mexico
- 3Everything you should know before booking a trip to Spain
- 4CDC vaccine panel votes to remove universal hepatitis B birth dose recommendation
- 5James Webb Space telescope spots 'big red dot' in the ancient universe: A ravenous supermassive black hole named 'BiRD'
- Photos: Presidential turkey pardons — a look back
- Vote In favor of Your Favored Occasion Arranging Administration
- Misremembering might actually be a sign your memory is working optimally
- Find the Keys to Fruitful Venture The board: Conveying Results on Time
- Exploring the Mind boggling Universe of Connections: Individual Bits of knowledge
- 'No middle ground' for tackling antisemitism after Bondi Beach mass shooting, deputy FM Haskel says
- Top Smoothie Flavor: What's Your Mix?
- How on earth did 'Shark Tank' star Kevin O'Leary end up in 'Marty Supreme'? I'll let him explain.
- Raw oysters linked to ongoing salmonella outbreak infecting 64 across 22 states: CDC
